| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA5196482
Max Phase: Preclinical
Molecular Formula: C18H18FN5O
Molecular Weight: 339.37
Associated Items:
Representations
Canonical SMILES: CCN(Cc1cc2c(=O)n(CCC#N)ccn2n1)c1ccc(F)cc1
Standard InChI: InChI=1S/C18H18FN5O/c1-2-22(16-6-4-14(19)5-7-16)13-15-12-17-18(25)23(9-3-8-20)10-11-24(17)21-15/h4-7,10-12H,2-3,9,13H2,1H3
Standard InChI Key: SCCZJCOIRVYXNF-UHFFFAOYSA-N
Associated Targets(Human)
Glutamate NMDA receptor; GRIN1/GRIN2A 719 Activities
Glutamate receptor ionotropic, AMPA 2 847 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 339.37 | Molecular Weight (Monoisotopic): 339.1495 | AlogP: 2.58 | #Rotatable Bonds: 6 |
| Polar Surface Area: 66.33 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 0 |
| #RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: | CX Basic pKa: 1.08 | CX LogP: 1.99 | CX LogD: 1.99 |
| Aromatic Rings: 3 | Heavy Atoms: 25 | QED Weighted: 0.69 | Np Likeness Score: -2.15 |
References
| 1. Sakurai F, Yukawa T, Kina A, Murakami M, Takami K, Morimoto S, Seto M, Kamata M, Yamashita T, Nakashima K, Narita N, Bettini E, Ugolini A, Corsi M, Hasui T.. (2022) Discovery of Pyrazolo[1,5-a]pyrazin-4-ones as Potent and Brain Penetrant GluN2A-Selective Positive Allosteric Modulators Reducing AMPA Receptor Binding Activity., 56 [PMID:35051811] [10.1016/j.bmc.2021.116576] |
Source
Source(1):